Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Long-Term Debt Repayments (2021 - 2022)

Updated

Oncotelic Therapeutics (OTLC) reported Long-Term Debt Repayments of $440,000 for Q2 2022, up 780.0% from $50,000 a year earlier and up 633.3% from the prior quarter.

Analysis

Oncotelic Therapeutics (OTLC) Long-Term Debt Repayments (2021 - 2022) Analysis & Trends

For FY2021, Oncotelic Therapeutics posted Long-Term Debt Repayments of $100,000, up 100.0% from FY2020.

  • By year, Long-Term Debt Repayments came in at $50,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 1.00 Mn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 2.00 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 2.46 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn -
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 17.00 Mn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn -
10 Oncotelic Therapeutics 8.28 Mn 7.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -60,000.00
Jun 30, 2022 500,000.00
Mar 31, 2022 60,000.00
Dec 31, 2021 307,500.00
Jun 30, 2021 50,000.00
Mar 31, 2021 50,000.00
API Access

Oncotelic Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=OTLC&period=max&api_key=YOUR_API_KEY